Inflammation is a key feature of NASH, and the NLRP3 and AIM2 inflammasomes have been shown to be activated in liver immune cells under multiple experimental conditions [132]. This evidence concerns the gene NLRP3 and metabolic dysfunction-associated steatohepatitis.